Seylani, A., Haile, Y., Sadighian, A. (2025). Risk of autoimmune hepatitis, non-infectious gastroenteritis, and colitis among patients with metastatic clear cell renal cell carcinoma (ccRCC) treated with pembrolizumab/axitinib vs nivolumab/ipilimumab.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16530